Figure 2 | Scientific Reports

Figure 2

From: Serum neurofilament light chain levels as a biomarker of neuroaxonal injury and severity of oxaliplatin-induced peripheral neuropathy

Figure 2

Relationship between serum neurofilament light chain levels at 6 months and main outcome measures. Sensory score of the EORTC QLQ-CIPN20 (A), and a-SAP (µV) of the sural nerve (B), median nerve (C), and ulnar nerve (D). The scatterplot shows regression lines and 95% confidence intervals. sNfL: serum neurofilament light chain, EORTC QLQ-CIPN20: European Organization for Research and Treatment of Cancer Quality of Life Questionnaire-Chemotherapy-Induced Peripheral Neuropathy 20 module.

Back to article page